We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Acadia Pharmaceuticals
ACAD
$5.03B
| $94M | 0.04% |
2,196,918
+642,321
| +41% | +$27.9M |
|
427
CoStar Group
CSGP
$12.3B
| $93.9M | 0.04% |
1,569,210
-46,140
| -3% | -$2.69M |
|
428
Eversource Energy
ES
$27.2B
| $93.4M | 0.04% |
1,097,615
-199,766
| -15% | -$16.6M |
|
|
IPG
429
DELISTED
Interpublic Group of Companies
IPG
| $92.9M | 0.04% |
4,020,523
-439,094
| -10% | -$9.65M |
|
430
Capri Holdings
CPRI
$1.74B
| $92.5M | 0.04% |
2,425,146
-79,750
| -3% | -$2.75M |
|
431
LyondellBasell Industries
LYB
$19.2B
| $92.5M | 0.04% |
979,201
-266,204
| -21% | -$24.4M |
|
432
Terreno Realty
TRNO
$7.49B
| $92.1M | 0.03% |
1,701,936
-225,551
| -12% | -$12.3M |
|
433
Fastenal
FAST
$59.5B
| $91.9M | 0.03% |
4,973,576
-172,170
| -3% | -$3.08M |
|
434
UDR
UDR
$12.3B
| $91.8M | 0.03% |
1,965,266
-94,663
| -5% | -$4.55M |
|
435
Campbell Soup
CPB
$6.87B
| $91.2M | 0.03% |
1,846,349
-356,022
| -16% | -$16.9M |
|
436
FMC
FMC
$1.33B
| $91M | 0.03% |
911,837
+151,666
| +20% | +$14.1M |
|
437
Ameren
AEE
$30.1B
| $90.5M | 0.03% |
1,178,972
-764,837
| -39% | -$58.1M |
|
438
Incyte
INCY
$24.4B
| $90.4M | 0.03% |
1,034,800
-63,740
| -6% | -$5.45M |
|
|
DOC
439
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $90.3M | 0.03% |
4,769,218
+2,795,461
| +142% | +$51.3M |
|
440
Cooper Companies
COO
$14.5B
| $89.6M | 0.03% |
1,115,032
-53,112
| -5% | -$4.01M |
|
441
US Foods
USFD
$24B
| $89.4M | 0.03% |
2,134,219
-777,248
| -27% | -$31.2M |
|
442
Genpact
G
$5.81B
| $88.9M | 0.03% |
2,108,607
-34,723
| -2% | -$1.39M |
|
443
Centene
CNC
$32.5B
| $88.7M | 0.03% |
1,411,119
-474,629
| -25% | -$25.7M |
|
444
Mettler-Toledo International
MTD
$28.6B
| $88.1M | 0.03% |
111,066
-3,492
| -3% | -$2.52M |
|
445
Teledyne Technologies
TDY
$32B
| $87.9M | 0.03% |
253,700
+6,939
| +3% | +$2.33M |
|
446
Euronet Worldwide
EEFT
$2.7B
| $87.4M | 0.03% |
554,923
-53,016
| -9% | -$8M |
|
447
JD.com
JD
$44.5B
| $87.4M | 0.03% |
2,480,324
+363,100
| +17% | +$11.7M |
|
448
Steris
STE
$23.1B
| $87.3M | 0.03% |
572,484
-18,849
| -3% | -$2.76M |
|
449
Delek US
DK
$3.58B
| $86.8M | 0.03% |
2,589,751
-1,371,824
| -35% | -$49.5M |
|
450
Energizer
ENR
$1.55B
| $86.8M | 0.03% |
1,728,978
+224,607
| +15% | +$10.3M |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.